Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

ABT110 Anti-SDHD (CybS) Antibody

View Products on Sigmaaldrich.com
ABT110
100 µg  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
H, MWB, ICCRbAffinity PurifiedPolyclonal Antibody
Description
Catalogue NumberABT110
DescriptionAnti-SDHD (CybS) Antibody
Alternate Names
  • Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
  • CybS
  • CII-4
  • QPs3
  • Succinate dehydrogenase complex subunit D
  • Succinate-ubiquinone oxidoreductase cytochrome b small subunit
  • Succinate-ubiquinone reductase membrane anchor subunit
Background InformationSuccinate dehydrogenase complex subunit D (SDHD) is a member of the CybS family and is one of four subunits of the succinate dehydrogenase (SDH) complex involved in the electron transport chain of the mitochondria. The specific role of SDH is to transfer electrons from succinate to ubiquinone, and the SDHD subunit is involved in anchoring the SDH complex to the inner mitochondrial membrane. Defective SDHD has been linked to Carney-Stratakis syndrome, a condition characterized by concurrent paraganglioma and gastric stromal sarcomas.
References
Product Information
FormatAffinity Purified
Control
  • HeLa cell lysate.
PresentationPurified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationThis Anti-SDHD (CybS) Antibody is validated for use in Western Blotting, ICC for the detection of SDHD (CybS).
Key Applications
  • Western Blotting
  • Immunocytochemistry
Application NotesImmunocytochemistry Analysis: A 1:500 dilution from a representative lot detected SDHD (CybS) in NIH/3T3 and HeLa cells.
Biological Information
ImmunogenKLH-conjugated linear peptide corresponding to the Topological domain of human SDHD (CybS).
EpitopeTopological domain (mitochondrial matrix)
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostRabbit
SpecificityThis antibody recognizes the Topological domain (mitochondrial matrix) of SDHD (CybS).
Species Reactivity
  • Human
  • Mouse
Species Reactivity NoteDemonstrated to react with Human and Mouse. Predicted to react with Bovine, Sheep, and Rhesus Macaque based on 100% sequence homology. Other homologies: Rat (92% sequence homology).
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene SummaryComplex II of the respiratory chain, which is specifically involved in the oxidation of succinate, carries electrons from FADH to CoQ. The complex is composed of four nuclear-encoded subunits and is localized in the mitochondrial inner membrane. The subunit D protein is one of two integral membrane proteins anchoring the complex to the matrix side of the membrane. Mutations in SDHD have been linked to hereditary paraganglioma.
Gene Symbol
  • SDHD
  • SDH4
Purification MethodAffinity Purfied
UniProt Number
UniProt SummaryFUNCTION: Membrane-anchoring subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q).

PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle.

SUBUNIT STRUCTURE: Component of complex II composed of four subunits: the flavoprotein (FP) SDHA, iron-sulfur protein (IP) SDHB, and a cytochrome b560 composed of SDHC and SDHD.

SUBCELLULAR LOCATION: Mitochondrion inner membrane; Multi-pass membrane protein.

INVOLVEMENT IN DISEASE: Defects in SDHD are a cause of paragangliomas type 1 (PGL1). A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. PGL1 is a rare autosomal dominant disorder which is characterized by the development of mostly benign, highly vascular, slowly growing tumors in the head and neck. In the head and neck region, the carotid body is the largest of all paraganglia and is also the most common site of the tumors. Defects in SDHD are a cause of susceptibility to pheochromocytoma (PCC) [MIM:171300]. A catecholamine-producing tumor of chromaffin tissue of the adrenal medulla or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of epinephrine and norepinephrine, is hypertension, which may be persistent or intermittent. Defects in SDHD may be a cause of susceptibility to intestinal carcinoid tumor (ICT). A yellow, well-differentiated, circumscribed tumor that arises from enterochromaffin cells in the small intestine or, less frequently, in other parts of the gastrointestinal tract. Defects in SDHD are a cause of paraganglioma and gastric stromal sarcoma (PGGSS); also called Carney-Stratakis syndrome. Gastrointestinal stromal tumors may be sporadic or inherited in an autosomal dominant manner, alone or as a component of a syndrome associated with other tumors, such as in the context of neurofibromatosis type 1 (NF1). Patients have both gastrointestinal stromal tumors and paragangliomas. Susceptibility to the tumors was inherited in an apparently autosomal dominant manner, with incomplete penetrance. Defects in SDHD are a cause of Cowden-like syndrome (CWDLS). Cowden-like syndrome is a cancer predisposition syndrome associated with elevated risk for tumors of the breast, thyroid, kidney and uterus.

SEQUENCE SIMILARITIES: Belongs to the CybS family.
Molecular Weight~11 kDa observed. An uncharacterized band may be observed at ~25 kDa in some cell lysates.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blot in HeLa cell lysate.

Western Blot Analysis: 1 µg/mL of this antibody detected SDHD (CybS) in 10 µg of HeLa cell lysate.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
ABT110 04053252550195

Documentation

Anti-SDHD (CybS) Antibody SDS

Title

Safety Data Sheet (SDS) 

Anti-SDHD (CybS) Antibody Certificates of Analysis

TitleLot Number
Anti-SDHD (CybS) - 2147120 2147120
Anti-SDHD (CybS) - 2327010 2327010
Anti-SDHD (CybS) - 3275056 3275056
Anti-SDHD (CybS) - 3386435 3386435
Anti-SDHD (CybS) - 4164240 4164240
Anti-SDHD (CybS) - Q2005663 Q2005663
Anti-SDHD (CybS) -2567133 2567133
Anti-SDHD (CybS) -2720128 2720128
Anti-SDHD (CybS) -2822019 2822019
Anti-SDHD (CybS) Polyclonal Antibody 3063429

References

Reference overviewPub Med ID
A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal cardiomyopathy and a severe mitochondrial complex II deficiency.
Alston, CL; Ceccatelli Berti, C; Blakely, EL; Oláhová, M; He, L; McMahon, CJ; Olpin, SE; Hargreaves, IP; Nolli, C; McFarland, R; Goffrini, P; O'Sullivan, MJ; Taylor, RW
Human genetics  134  869-79  2015

Show Abstract
26008905 26008905

Brochure

Title
New Products: Volume 3, 2012